Edition:
India

Puma Biotechnology Inc (PBYI.N)

PBYI.N on New York Stock Exchange

30.62USD
24 Jun 2016
Change (% chg)

$-3.03 (-9.00%)
Prev Close
$33.65
Open
$32.15
Day's High
$32.36
Day's Low
$30.50
Volume
1,130,780
Avg. Vol
125,744
52-wk High
$126.47
52-wk Low
$19.74

PBYI.N

Chart for PBYI.N

About

Puma Biotechnology, Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on in-licensing the global development and commercialization rights to over three drug candidates, including PB272 (neratinib (oral)), which the Company is... (more)

Overall

Beta: 0.02
Market Cap(Mil.): $994.94
Shares Outstanding(Mil.): 32.49
Dividend: --
Yield (%): --

Financials

BRIEF-Paulson & Co ups share stake in Puma Biotechnology Inc by 52.8 pct to 70,300 shares - Sec Filing

* Paulson & Co ups share stake in Puma Biotechnology Inc by 52.8 pct to 70,300 shares - Sec Filing

17 May 2016

BRIEF-Puma Biotechnology reports Q1 loss per share $2.19

* Puma biotechnology reports first quarter 2016 financial results

11 May 2016

Earnings vs. Estimates